(ADVISORY- Follow European and UK stock markets in real time onthe Reuters Live Markets blog on Eikon - see cpurl://apps.cp./cms/?pageId=livemarkets)
MILAN, Nov 4 (Reuters) - European shares fell in early tradeon Friday weighed down by weaker drugmakers after two U.S.lawmakers called on federal antitrust regulators to open a probefor possible price fixing.
By 0822 GMT, the pan-European STOXX 600 index fell0.7 percent, while Europe's STOXX Healthcare subindex,down 1.6 percent, was the biggest sectoral faller.
The U.S. lawmakers on Thursday called to probe whetherSanofi, Eli Lilly and Co, Merck & Co Inc and Novo Nordisk A/S colluded to set pricesfor insulin and other diabetes drugs. Sanofi and Novo Nordiskwere down 1.6 and 2.5 percent respectively.
Top faller in the sector was Hikma, which was hit bya price target cut at HSBC on concerns over U.S. regulatoryinvestigations into price collusion in the pharma market.
French outdoor advertising company JCDecaux wasalso down, dropping 7 percent on a disappointing revenue growthoutlook.
But Richemont rose 6 percent after the luxury goodsgroup announce a management revamp following the release of itsquarterly results which a trader said beat estimates. (Reporting by Danilo Masoni; Editing by Alistair Smout)